| 7748 |
Centers for Disease Control and Prevention |
Html |
en |
Flu Activity - Current Season 2012 |
[Title] |
| Noon E.T | 0.527579 |
| Centers | 0.43985 |
| reports | 0.419276 |
| media availability | 0.512691 |
| Monday | 0.448336 |
| Non-Media | 0.439865 |
| Acting Director | 0.512435 |
| importance | 0.418004 |
| CDC web site | 0.667238 |
| M.D. | 0.433401 |
| Melinda Wharton | 0.528714 |
| important step | 0.520168 |
| Prevention | 0.439771 |
| www.cdc.gov/flu | 0.419206 |
| mid-season figures | 0.584467 |
| Disease Control | 0.639208 |
| U.S. DEPARTMENT | 0.507134 |
| M.P.H. | 0.41903 |
| NIVW | 0.461872 |
| PASSCODE | 0.436987 |
| telephone-only media briefing | 0.692183 |
| annual flu vaccination | 0.769163 |
|
| vaccination rates | 0.675462 |
| National Influenza Vaccination | 0.951098 |
| dial | 0.421444 |
| National Center | 0.51762 |
| Immunization | 0.425182 |
| CDC Media | 0.584677 |
| question | 0.465864 |
| U.S. influenza activity | 0.727875 |
| flu viruses | 0.536293 |
| touchtone phone | 0.522252 |
| Dec. | 0.421799 |
| mid-season vaccination coverage | 0.793624 |
| Announces National Influenza | 0.744003 |
| Thomas R. Frieden | 0.631567 |
| Respiratory Diseases | 0.51759 |
| HUMAN SERVICES | 0.508422 |
| information | 0.419307 |
| websites | 0.419221 |
| time | 0.418613 |
| 15 minutes | 0.417905 |
| press conference | 0.509694 |
| INTERNATIONAL | 0.419563 |
|
CLICK HERE |
| 8760 |
Centers for Disease Control and Prevention |
Html |
en |
Study suggests only half of Americans with hepatitis C receive complete testing |
Study suggests only half of Americans with hepatitis C receive complete testing for the virus |
| liver transplants. | 0.375192 |
| CDC reinforces | 0.468577 |
| Disease Control | 0.372106 |
| antibody-positive results | 0.350933 |
| hepatitis C test | 0.737203 |
| liver cancer. Hepatitis | 0.803564 |
| health care providers | 0.455858 |
| National Hepatitis Testing | 0.783135 |
| liver damage | 0.370082 |
| enhanced surveillance | 0.344006 |
| Vital Signs | 0.672902 |
| follow-up testing | 0.736031 |
| cancer-related death | 0.352212 |
| Complete testing | 0.379574 |
| new effective treatments | 0.662892 |
| necessary follow-up test | 0.603506 |
| CDC’s Division | 0.418389 |
| appropriate follow-up testing | 0.625014 |
| noticeable symptoms | 0.354017 |
| severe impact | 0.347467 |
| especially baby boomers | 0.485969 |
| antibody-positive tests | 0.353539 |
| hepatitis C testing | 0.655193 |
| United States | 0.449151 |
|
| antibody test result | 0.734966 |
| percent | 0.351334 |
| hepatitis C cases | 0.687967 |
| CDC Director Tom | 0.571383 |
| significant health problems | 0.483431 |
| hepatitis C testing. | 0.639854 |
| appropriate medical care | 0.473064 |
| blood test | 0.38253 |
| current infection | 0.687155 |
| hepatitis C virus | 0.679055 |
| follow-up RNA testing | 0.551114 |
| testing technologies | 0.355853 |
| Hepatitis Awareness | 0.649173 |
| Vital Signs study | 0.47561 |
| multi-area study | 0.379965 |
| hepatitis | 0.950043 |
| people | 0.372117 |
| positive antibody test | 0.731909 |
| baby boomers | 0.629393 |
| follow-up test | 0.693386 |
| CDC report Vital | 0.596064 |
| hepatitis C. CDC | 0.814179 |
| Prevention analysis | 0.368542 |
| small number | 0.356832 |
|
CLICK HERE |
| 9139 |
Centers for Disease Control and Prevention |
Html |
en |
Asthma - Interventions - Case Studies - The Roaring Adventures of Puff - Program Components |
Interventions - Case Studies - The Roaring Adventures of Puff - Program Components |
| overhead slide presentation | 0.297601 |
| P.O. Box | 0.226919 |
| Asthma Education Program | 0.716971 |
| RAP instructor | 0.373321 |
| peak flow numbers | 0.290909 |
| Details instructor qualification | 0.327802 |
| contact information forms | 0.314143 |
| 1-2 hour meeting | 0.21355 |
| Participant descriptions | 0.210324 |
| course evaluation forms | 0.306311 |
| children | 0.288678 |
| health care professionals | 0.289456 |
| school issues | 0.22101 |
| reliever medications | 0.22131 |
| participant issues | 0.221072 |
| Asthma Worse | 0.528011 |
| Asthma Action Plan | 0.628323 |
| Asthma symptom recognition | 0.597458 |
| asthma jeopardy game | 0.576006 |
| assessment forms | 0.224925 |
| asthma | 0.910504 |
| asthma attack | 0.591257 |
| development process | 0.220818 |
| RAP education program | 0.424539 |
| various ages | 0.214132 |
|
| health education programs | 0.319062 |
| asthma severity zones | 0.593805 |
| older children | 0.233448 |
| peak flow | 0.307465 |
| important asthma treasure | 0.594253 |
| program components | 0.245357 |
| session | 0.281431 |
| ) course. | 0.416592 |
| asthma triggers | 0.515742 |
| Fun Book | 0.211784 |
| social development issues | 0.314784 |
| South Carolina | 0.226828 |
| MAS Consultants Inc. | 0.332626 |
| educational package | 0.226435 |
| RAP train-the-trainer course | 0.414204 |
| asthma-friendly school policy | 0.294183 |
| warning signs | 0.286408 |
| healthy lungs | 0.211629 |
| airway models | 0.2124 |
| children’s questionnaire | 0.243651 |
| Canadian Asthma Consensus | 0.584342 |
| peak flow meter | 0.295516 |
| asthma symptoms | 0.496391 |
| session progress | 0.253357 |
|
CLICK HERE |
| 10068 |
Centers for Disease Control and Prevention |
Html |
en |
Silica, Engineering Controls for Silica in Construction - Jackhammer - NIOSH Workplace Safety and Health Topic |
This NIOSH Topic Page presents information and links to other resources about Silica and Silicosis, and provides information to help workers protect themselves from occupational exposure to Silica. |
| spray angle | 0.444418 |
| dust exposures | 0.463107 |
| pneumatic jackpicks | 0.361943 |
| Lower flow rates | 0.36799 |
| ounces | 0.221669 |
| water spray device | 0.425363 |
| spray pattern | 0.348777 |
| concrete pavement | 0.30981 |
| commercially available retrofit | 0.38719 |
| water attachments | 0.300494 |
| water-spray control | 0.389213 |
| bar | 0.23342 |
| water-spray attachment | 0.313414 |
| respirable crystalline silica | 0.499977 |
| built-in water-spray units | 0.382806 |
| water sprays | 0.303112 |
| dust control | 0.528751 |
| solid-cone nozzle | 0.307518 |
| atomisation | 0.222117 |
| Construction workers | 0.312524 |
| handheld demolition | 0.288919 |
| crystalline silica dust | 0.493448 |
| hazardous dust | 0.455244 |
| soil compacting equipment | 0.367792 |
| dust controls | 0.412905 |
|
| water spray | 0.488511 |
| airborne dust | 0.463698 |
| water spray control | 0.441673 |
| RCS | 0.223105 |
| Workplace Solution | 0.296975 |
| milligrams | 0.2173 |
| jackhammer | 0.49457 |
| critical design parameters | 0.37504 |
| Engineering Controls video | 0.905447 |
| cubic meter | 0.303505 |
| E.E. Cruz Company | 0.360473 |
| Download | 0.233046 |
| South Plainfield | 0.290005 |
| In-depth survey report | 0.35853 |
| critical design parameter | 0.375542 |
| water flow rates | 0.3822 |
| NIOSH partner | 0.322022 |
| water flow rate | 0.38364 |
| right | 0.233393 |
| 80-degree spray angle | 0.443467 |
| New Jersey | 0.28859 |
| respirable dust exposure | 0.729503 |
| critical design | 0.389734 |
| jackhammers | 0.301418 |
|
CLICK HERE |
| 11116 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Frequently Asked Questions |
null |
| critical nutritional data | 0.489793 |
| CDC | 0.578789 |
| CDC’s National | 0.50361 |
| Page | 0.498643 |
| nutritional status—biochemical measurements—that | 0.480431 |
| dietary supplements. | 0.500183 |
| Potential public health | 0.481184 |
| public health uses | 0.53209 |
| health outcomes | 0.474164 |
| CDC’s nutrition | 0.498285 |
| problems. Independent research | 0.519649 |
| Nutrition Examination Survey | 0.53271 |
| new biochemical indicators | 0.607821 |
| CDC publication | 0.504241 |
| National Center | 0.470777 |
| general U.S. population | 0.537987 |
| public health officials | 0.528487 |
| potential health relevance. | 0.481832 |
| CDC fact sheet | 0.490162 |
| National Health | 0.481386 |
| biochemical indicators | 0.987504 |
| Environmental Health Laboratory | 0.485056 |
| first-of-its-kind report | 0.475742 |
| human health studies | 0.478686 |
| Web site | 0.48719 |
|
| wide range | 0.470235 |
| nutritional status—biochemical measurements—other | 0.488759 |
| demographic reference information | 0.471511 |
| 95th percentile levels | 0.479176 |
| urine. Biochemical indicators | 0.629714 |
| nutrition report | 0.555628 |
| iron-status indicators | 0.532959 |
| u.s. population | 0.64923 |
| public health | 0.571881 |
| National Report | 0.480678 |
| nutritional status | 0.715754 |
| health problems. Independent | 0.531186 |
| adequate biochemical levels | 0.614049 |
| comprehensive reference information | 0.48698 |
| population reference levels | 0.488905 |
| biochemical indicator | 0.660663 |
| special population groups | 0.473385 |
| food safety | 0.475362 |
| public health efforts | 0.524104 |
| 90th percentile levels | 0.479107 |
| report | 0.679999 |
| information | 0.520938 |
| nutritional indicators | 0.52382 |
| related biochemical compounds | 0.554598 |
|
CLICK HERE |
| 11571 |
Centers for Disease Control and Prevention |
Html |
en |
NER - Peer-Reviewed Biomonitoring Articles | Perfluorinated Compounds |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 13284 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Interim NIOSH Training for Emergency Responders -Reducing Risks Associated with Long Work Hours |
CDC - Wide Page example example description goes here |
| DART | 0.510013 |
| Applied Research | 0.733474 |
| NIOSH | 0.744714 |
| Health | 0.494014 |
| conclusions | 0.555284 |
| findings | 0.524603 |
|
| Occupational Safety | 0.99647 |
| Content source | 0.745299 |
| report | 0.463526 |
| Division | 0.455277 |
| National Institute | 0.86254 |
| views | 0.461883 |
|
CLICK HERE |
| 13350 |
Centers for Disease Control and Prevention |
Html |
en |
Use of Serogroup B Meningococcal Vaccines in Persons Aged?10 Years at Increased Risk for Serogroup B Meningococcal Disease:Recommendations of the Advisory Committee on ImmunizationPractices, 2015 |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| United States | 0.632213 |
| meningococcal disease epidemiology | 0.668464 |
| Vaccines Work Group | 0.675167 |
| certain groups | 0.582276 |
| 10,000-fold increased risk | 0.593908 |
| Vaccine Preventable Diseases | 0.580301 |
| geometric mean titer | 0.622728 |
| serogroup B strains | 0.605565 |
| Immunization Practices | 0.601776 |
| concomitant vaccine antigens | 0.582119 |
| meningococcal conjugate vaccine | 0.656831 |
| college students | 0.578159 |
| meningococcal laboratory workers | 0.6338 |
| Practices Meningococcal Vaccines | 0.665088 |
| clinical trials | 0.771176 |
| composite hSBA response | 0.746743 |
| increased risk | 0.600454 |
| 3-dose series | 0.592511 |
| National Center | 0.581687 |
| ACIP Meningococcal Vaccines | 0.752952 |
| test strains | 0.692009 |
| 2-dose series | 0.593897 |
| lower limit | 0.578902 |
|
| vaccine efficacy estimates | 0.584616 |
| immunogenicity extension study | 0.579118 |
| MenB-FHbp | 0.597642 |
| Serogroup B Meningococcal | 0.709639 |
| subjects | 0.587884 |
| MenB vaccine | 0.628376 |
| unpublished data | 0.814859 |
| Vaccine Adverse Event | 0.592082 |
| serogroup B. | 0.58145 |
| adverse events | 0.711348 |
| immunogenicity data | 0.584196 |
| MenB vaccines | 0.802786 |
| meningococcal disease | 0.969736 |
| persons | 0.692122 |
| study investigator | 0.57989 |
| serogroup | 0.710073 |
| Novartis Vaccines | 0.578082 |
| laboratory-acquired meningococcal infection | 0.6458 |
| Respiratory Diseases | 0.578706 |
| mean titer ratio | 0.623206 |
| risk | 0.617661 |
| human papillomavirus vaccine | 0.580573 |
| Meningococcal Vaccines Work | 0.753519 |
|
CLICK HERE |
| 14443 |
Centers for Disease Control and Prevention |
Html |
en |
ADHD in Young Children |
CDC Vital Signs links science, policy, and communications with the intent of communicating a call-to-action for the public. CDC Vital Signs provides the most recent, comprehensive data on key indicators of important health topics. |
| healthcare providers | 0.492482 |
| ADHD | 0.911518 |
| CDC | 0.234353 |
| specific ways | 0.376195 |
| instances | 0.238552 |
| behavior therapy | 0.552587 |
| webinar series | 0.383589 |
| training | 0.230808 |
| potential providers | 0.359336 |
| Attention-deficit/hyperactivity disorder | 0.414491 |
| biological disorder | 0.391211 |
| effective treatment | 0.366894 |
| relationships | 0.231386 |
| Clinical guidelines | 0.373373 |
| young children | 0.847149 |
| health care professionals | 0.497063 |
| important first step | 0.380221 |
|
| therapists | 0.233375 |
| families | 0.260049 |
| psychological services | 0.368353 |
| Behavioral Health | 0.360976 |
| impulsiveness | 0.262864 |
| child’s behavior | 0.371235 |
| appropriate treatment | 0.35931 |
| key role | 0.395515 |
| effects | 0.23268 |
| attention problems | 0.399326 |
| ADHD treatment recommend | 0.701261 |
| National Council | 0.368333 |
| information | 0.229609 |
| ADHD symptoms | 0.57869 |
| ADHD medicine | 0.546865 |
| support | 0.231701 |
|
CLICK HERE |
| 15494 |
Centers for Disease Control and Prevention |
Html |
en |
#DoingIt | Campaigns | Act Against AIDS |
Doing It is a social marketing campaign designed to motivate all adults to get tested for HIV and know their status. The campaign drives home the message that HIV testing is a normal part of life and everyone is doing it |
| regular health | 0.684866 |
| Campaign posters | 0.711583 |
| new national HIV | 0.958416 |
| palm cards | 0.713525 |
| adults | 0.451532 |
| prevention campaign | 0.680797 |
| message | 0.449818 |
| banners | 0.454361 |
|
| PSAs | 0.535513 |
| Act | 0.450239 |
| AIDS initiative | 0.706947 |
| HIV testing | 0.950919 |
| social media | 0.716009 |
| movement | 0.454892 |
| video testimonials | 0.712687 |
|
CLICK HERE |